Citius Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial of its Mino-Lok® Therapeutic to Salvage Catheters
Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has completed enrollment in its pivotal Phase 3 clinical trial for Mino-Lok®, an…
Newton Dentist Utilizes Oral Appliance Therapy to Treat Sleeping Disorders
Newton Dentistry provides a range of treatment options for snoring patients and sleep apnea patients. Dr. Yoon Ji Jang, who has experience in dental sleep medicine as well as sedation, provides sleep apnea treatment as an alternative to continuous positive airway…
Zeal Specialty Pharmacy Credentialed in Record Time
Since opening their doors in March of 2023, Zeal Specialty Pharmacy has obtained licensure in all 50 states, Specialty Pharmacy Accreditation from URAC and the Accreditation Commission for Health Care (ACHC), and a Rare Disease & Orphan Drug Designation from…
Signia Marks a New Era with the Inauguration of its 350th BestSound Center in Partnership with HearSens Hearing Clinic in Hyderabad
Signia, a distinguished brand within the WS Audiology group and a leader in hearing aid innovation, celebrates a significant milestone with the launch of its 350th BestSound Center in Hyderabad. This milestone underscores Signia’s pivotal role in revolutionizing hearing care…
Navamedic ASA: Renewed contract signed with Vitaflo International Limited
Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces it has renewed its contract with Vitaflo International Limited (Vitaflo International), granting Navamedic the exclusive rights to market and distribute Vitaflo…
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
Alkermes plc (Nasdaq: ALKS) today announced that it has entered into a definitive agreement to sell its development and manufacturing facility in Athlone, Ireland to Novo Nordisk, a leading global healthcare company. Under the terms of the agreement, upon the closing of the transaction,…
Venus Remedies expands global presence with marketing authorisation for enoxaparin from Azerbaijan
Venus Remedies Limited, a leading fixed-dosage injectable manufacturer, has reached a significant milestone with a marketing authorisation from Azerbaijan for the first time for enoxaparin, an anticoagulant that plays a crucial role in addressing blood clot formation in patients suffering…
Only 7% of Indian Doctors Aware of Recent Advances in Anti-Smoking Strategies: Reveals IMAPH Survey
In a groundbreaking survey conducted by the Indian Medical Academy for Preventive Health (IMAPH), prominent doctors in India underwent scrutiny regarding their knowledge and awareness of anti-smoking strategies. The findings revealed alarming gaps, with a mere 7% of doctors demonstrating…
Trillium Health Partners to become first in Canada to deploy AI in diagnostic imaging using Sectra Amplifier Services
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) helps Trillium Health Partners (THP) in Canada adopt AI technology with new AI-as-a-service agreement via Sectra Amplifier Services. This will enable THP to introduce AI-powered workflows in its diagnostic imaging department, which will…
Apotex Corp. Launches Teriparatide Injectable for Osteoporosis Treatment in the United States
Apotex Corp. announced today the launch of Teriparatide Injection, a single-patient-use pre-filled pen used for the treatment of osteoporosis in the United States. Teriparatide Injection is supplied as a single-patient-use pre-filled pen containing 250 mcg/mL, capable of administering 28 daily doses…
